Sergey Jakimov

Sergey Jakimov, Founding Partner at LongeVC, is a seasoned entrepreneur and venture capitalist specializing in biotech and longevity investments. In this engaging discussion, he emphasizes the importance of practical, science-backed approaches to longevity over hype. Sergey explains why aging isn’t classified as a disease, dives into AI's revolutionary impact on drug discovery, and highlights the burgeoning market of pet longevity. He also shares insights on how LongeVC evolved from a modest fund to raising $250M with an impressive record.

In this engaging conversation with Sergey Jakimov, Managing Partner of LongeVC and co-founder of the Longevity Science Foundation, listeners dive into the exciting world of longevity-focused venture capital. Sergey shares his journey from aspiring neurosurgeon to investor, shedding light on LongeVC's unique strategy of targeting disease-modifying therapies. Key discussions include successful partnerships with major pharma, pitfalls in biotech investments, and the critical need for clear regulatory pathways. It's a fascinating look at how to transform research into viable commercial ventures in the longevity space.